Stavudine

HIV reverse transcriptase inhibitor

Stavudine

HIV reverse transcriptase inhibitor

From: 1,364 USD
Catalog #
(Select a product)
HIV reverse transcriptase inhibitor
Add to Wish List

Overview

Inhibit HIV replication and cancer cell growth with stavudine, a nucleoside analog of thymidine and HIV reverse transcriptase inhibitor (Tai-Shun et al.). After phosphorylation by kinases, stavudine turns into stavudine triphosphate, a compound that competes with the natural substrate thymidine triphosphate for incorporation into viral DNA by HIV reverse transcriptase . When stavudine triphosphate is incorporated into the viral DNA chain, it terminates DNA replication prematurely and inhibits HIV replication (Hurst & Noble).

Stavudine has been used for:

CANCER RESEARCH
· Induces mitochondrial reactive oxygen species (ROS) and enhances mitochondrial oxidative stress in human hepatoma cells (Velsor et al.).
· Reported to induce cellular senescence in human fibroblasts. Fibroblasts treated with stavudine exhibited mitochondrial dysfunction, slowed division rates, and increased ROS levels in early culture passages. In later passages, fibroblasts became senescent on the basis of p16 and p21 protein expression and senescence-associated-beta-galactosidase activity (Caron et al.).
DISEASE MODELING
· Reduces NLRP3 inflammasome-associated inflammation and stimulates Aβ autophagy by THP-1-derived macrophages in an in vitro model of Alzheimer's disease (La Rosa et al.).
Cell Type
Cancer Cells and Cell Lines
Area of Interest
Cancer, Disease Modeling
CAS Number
3056-17-5
Chemical Formula
C10H12N2O4
Molecular Weight
224.2 g/mol
Purity
≥ 98%

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Product Name
Stavudine
Catalog #
100-1167
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
Stavudine
Catalog #
100-1167
Lot #
All
Language
English